Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank-check company sponsored by Aimei Health Technology Ltd. that completed its initial public offering in 2022 with a focus on identifying acquisition targets in the health technology and life sciences sector, particularly businesses with operations or growth prospects in Asia. The company filed an amended annual report on Form 10-K/A with the SEC in August 2025, reflecting ongoing reporting obligations as the SPAC continues its search for a business combination target. Like many SPACs of its vintage, AFJK is registered in the Cayman Islands and trades on the Nasdaq Capital Market. Visit SpacDesk and create a free account to access full deal timelines, filing histories, and sponsor profiles for AFJK and hundreds of other active and completed SPAC transactions.